These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies. Dong Y; Zhou H; Alhaskawi A; Wang Z; Lai J; Yao C; Liu Z; Hasan Abdullah Ezzi S; Goutham Kota V; Hasan Abdulla Hasan Abdulla M; Lu H Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831535 [TBL] [Abstract][Full Text] [Related]
4. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types. Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165 [TBL] [Abstract][Full Text] [Related]
8. Design and Development of Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911 [TBL] [Abstract][Full Text] [Related]
9. Improved cancer detection in Waldeyer's tonsillar ring by Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927 [TBL] [Abstract][Full Text] [Related]
10. Fibroblast Activation Protein Inhibitor PET/CT: A Promising Molecular Imaging Tool. Sharma P; Singh SS; Gayana S Clin Nucl Med; 2021 Mar; 46(3):e141-e150. PubMed ID: 33351507 [TBL] [Abstract][Full Text] [Related]
11. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention. Loktev A; Lindner T; Burger EM; Altmann A; Giesel F; Kratochwil C; Debus J; Marmé F; Jäger D; Mier W; Haberkorn U J Nucl Med; 2019 Oct; 60(10):1421-1429. PubMed ID: 30850501 [TBL] [Abstract][Full Text] [Related]
12. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144 [TBL] [Abstract][Full Text] [Related]
13. State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis. Sollini M; Kirienko M; Gelardi F; Fiz F; Gozzi N; Chiti A Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4396-4414. PubMed ID: 34173007 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746 [TBL] [Abstract][Full Text] [Related]
15. FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis? Dendl K; Koerber SA; Kratochwil C; Cardinale J; Finck R; Dabir M; Novruzov E; Watabe T; Kramer V; Choyke PL; Haberkorn U; Giesel FL Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638433 [TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation and pilot clinical study of [ Hu K; Li J; Wang L; Huang Y; Li L; Ye S; Han Y; Huang S; Wu H; Su J; Tang G Acta Pharm Sin B; 2022 Feb; 12(2):867-875. PubMed ID: 35256951 [TBL] [Abstract][Full Text] [Related]
18. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [ Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149 [TBL] [Abstract][Full Text] [Related]
19. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a Varasteh Z; Mohanta S; Robu S; Braeuer M; Li Y; Omidvari N; Topping G; Sun T; Nekolla SG; Richter A; Weber C; Habenicht A; Haberkorn UA; Weber WA J Nucl Med; 2019 Dec; 60(12):1743-1749. PubMed ID: 31405922 [TBL] [Abstract][Full Text] [Related]
20. PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application-A Literature Review. Taralli S; Lorusso M; Perrone E; Perotti G; Zagaria L; Calcagni ML Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]